(PR-inside.com) TORONTO, ONTARIO -- (Marketwire) -- 10/05/11 -- Gemoscan Canada, Inc. ("Gemoscan" or the "Corporation") (CNSX:GES) announces, subject to regulatory approval, the Board of Directors has approved, effective October 5, 2011, the grant of an aggregate of 500,000 stock options (the "Options") to directors, officers and employees of the Corporation. The Options are exercisable into Class A shares of Gemoscan at an exercise price of $0.37 per share. The Options all vest immediately and have a five year term to expiry. Gemoscan is a company listed and trading on the Canadian National Stock Exchange, symbol: GES. Neither the CNSX ..
More...
More...